Serina Therapeutics
25 hedge funds and large institutions have $1.6M invested in Serina Therapeutics in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
406% more capital inflows, than outflows
Capital inflows: $141K | Capital outflows: $27.8K
0.21% more ownership
Funds ownership: 3.38% → 3.59% (+0.21%)
0% more funds holding
Funds holding: 25 → 25 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$104K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$22.5K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.8K |
| 4 |
Tower Research Capital (TRC)
New York
|
+$1.21K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$27.8K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$30 |
| 3 |
Danske Bank
Copenhagen K,
Denmark
|
-$13 |
| 4 |
Fourpath Capital Management
Oklahoma City,
Oklahoma
|
-$13 |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$6 |
SER Hedge Fund Activity: Q4 2024 in Review
25 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q4 2024, worth a combined $1.6M — down 20% from $2.01M a quarter earlier.
Fund positioning in SER was balanced in Q4 2024: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $104K. The largest seller was Millennium Management, cutting an estimated $27.8K.
- 25 institutional investors held Serina Therapeutics (SER) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $1.6M of Serina Therapeutics stock for Q4 2024, down 20% quarter-over-quarter.
- 2 funds opened new Serina Therapeutics positions in Q4 2024 and 2 closed out, a net change of 0 holders.
- The largest Serina Therapeutics buyer in Q4 2024 was Vanguard Group, an estimated $104K added.
- The largest Serina Therapeutics seller in Q4 2024 was Millennium Management, an estimated $27.8K sold.
Based on aggregated 13F filings for Q4 2024.